PMN ProMIS Neurosciences Inc.
Company Analysis
Latest News
🟢 ProMIS Neurosciences is trading 5.26% up today on PMN310 clinical data momentum
ProMIS Neurosciences is trading at $14.00 (+5.26%) as investors continue to react to recent PMN310 clinical data showing the first human evidence of...
🔴 ProMIS Neurosciences is trading 5% down today on profit-taking following PMN310 clinical data updates
ProMIS Neurosciences is trading at $13.30 (5% down) as investors digest recent clinical updates and engage in profit-taking following a multi-day rally. • The...
🟢 ProMIS Neurosciences is trading 7.4% up today after presenting positive PMN310 clinical data at AAIC 2026
ProMIS Neurosciences is trading 7.4% up at $13.75 after presenting first-in-human evidence that its lead Alzheimer’s antibody, PMN310, successfully engages...
🟢 ProMIS Neurosciences is trading 12.5% up
ProMIS Neurosciences is trading at $14.40, up 12.5% from a comparison close of $12.80 during pre-market. This is a price-action follow-up, so a separate...
ProMIS Neurosciences Bounces Back on Alzheimer's Drug Momentum — But Can a $120M Biotech Survive a Giants' War?
Shares of ProMIS Neurosciences surged 7.7% in pre-market trading to $13.78, clawing back most of Friday's 10.2% drop, as investors continued to chase momentum...
🟢 ProMIS Neurosciences shares jump 7.7% on positive PMN310 human data from AAIC 2026
ProMIS Neurosciences is trading at $13.78 (7.7%) up in pre-market, driven by a significant clinical update. • The company today announced the first human...
🔴 ProMIS Neurosciences is trading 5.9% down today amid broader biotech sector weakness
ProMIS Neurosciences is trading 5.9% down at $13.41 amid a broader pullback in biotech and risk assets. • The decline appears tied to sector-wide weakness and...
🟢 ProMIS Neurosciences is trading 6.2% up today after Roth Capital initiates with a 'Strong Buy' rating
• ProMIS Neurosciences (PMN) is trading 6.2% up today at $14.63 following a "strong-buy" rating initiated by Roth Capital. • The upgrade by Roth Capital on...
🟢 ProMIS Neurosciences Inc. is trading 8.49% up in pre-market
PMN is trading at $14.70, up 8.49% in pre-market.
🟢 PMN is trading 5.4% up today on bullish analyst targets and Strong Buy consensus
PMN is trading 5.4% up now at $13.88 as the stock extends its recent rally fueled by bullish analyst coverage and large upside price targets. • Wall Street...
🟢 PMN is trading 5.3% up today on bullish analyst coverage and price target hikes
PMN is trading at $13.86 (5.3% up) as fresh bullish analyst attention and significant price target hikes drive investor optimism. • Cantor Fitzgerald...
ProMIS Neurosciences rated Overweight at Cantor Fitzgerald, eyes Alzheimer's trial data
Cantor Fitzgerald initiated research coverage of ProMIS Neurosciences (PMN) with an Overweight rating. The clinical-stage biotechnology firm develops antibody...
🟢 PMN makes sharp 13.0% jump
PMN is trading at $12.15, up 13.0% versus the comparison close of $10.75 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 PMN Dips 5.1% Amidst Broader Market Sell-off, Despite HC Wainwright & Co. Buy Rating Reiteration
PMN is trading 5.1% down at $10.15 today, pulling back from a multi-day climb, while major U.S. indices are broadly lower. * The decline comes despite H.C....
🟢 ProMIS Neurosciences Inc. is trading 5.1% up today following CEO summit presentation and Zacks upgrade
ProMIS Neurosciences Inc. is trading at $10.56 (up 5.1%), extending gains following a presentation by its CEO at the H.C. Wainwright Neuro Perspectives Expert...
🟢 ProMIS Neurosciences Inc. up 13.6% amid CEO's conference presentation and recent Zacks upgrade
• ProMIS Neurosciences Inc. is trading at $11.42 (13.6% up) in after-hours, rebounding from recent declines. • The company's CEO is presenting at the H.C....
🔴 ProMIS Neurosciences Inc. is trading 9.9% down today as it reverses an earlier technical rebound
ProMIS Neurosciences Inc. is trading at $9.19, down 9.9% in after-hours trading, as the stock reverses a technical bounce seen during the regular session. •...
🟢 ProMIS Neurosciences Inc. is trading 5.7% up today on technical rebound after recent volatility
ProMIS Neurosciences Inc. is trading 5.7% up today at $10.30, extending its recovery from last week’s sharp swings and a 6.17% decline on June 5. • The move...
🟢 ProMIS Neurosciences Inc. is trading 5.7% up today, extending its rebound from recent volatility
ProMIS Neurosciences Inc. is trading 5.7% up at $10.30, extending its rebound from last week’s volatility and a 6.17% drop on June 5. • The advance appears to...
🟢 ProMIS Neurosciences Inc. is trading 14.0% up today on a speculative rebound amid thin liquidity
ProMIS Neurosciences Inc. is trading 14.0% up today at $10.41, rebounding sharply after recent declines in early June despite a lack of new company-specific...